Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1

Conditions

Sarcoma 37Leiomyosarcoma 12Liposarcoma 10Sarcoma, Ewing 4Neoplasms 4Liposarcoma, Myxoid 4Sarcoma, Synovial 3Rhabdomyosarcoma 3Histiocytoma, Malignant Fibrous 3Sarcoma, Alveolar Soft Part 2Ovarian Neoplasms 2Osteosarcoma 2Neurofibrosarcoma 2Malignant mesenchymal tumor 2Ichthyosis, X-Linked 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Bone Neoplasms 2Wilms Tumor 1Solitary Fibrous Tumors 1Sarcoma, Endometrial Stromal 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Lung Neoplasms 1Leiomyosarcoma Uterus 1Hemangioendothelioma 1

Interventions

pembrolizumab 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Cyclophosphamide 5Radiosurgery 3Oncolytic Virotherapy 3Nivolumab 3Injections 3Gemcitabine 3Drug Therapy 3Biopsy 3fludarabine 2belinostat 2Riluzole 2Paclitaxel 2Ipilimumab 2Filgrastim 2Docetaxel 2Cisplatin 2Celecoxib 2Carboplatin 2Bortezomib 2Blood Specimen Collection 2Amifostine 2AH 111585 2tislelizumab 1spartalizumab 1seribantumab 1selpercatinib 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Trabectedin × Sarcoma × Clear all
NCT03496519 2018-10-09

Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors

University of Colorado, Denver

Phase 1 Withdrawn
SarcomaThoracic

Lung Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡